AR032208A1 - PHARMACEUTICAL COMPOSITION FOR TOPIC USE BASED ON CORTICOSTEROIDS FOR THE TREATMENT OF PHYMOSIS - Google Patents
PHARMACEUTICAL COMPOSITION FOR TOPIC USE BASED ON CORTICOSTEROIDS FOR THE TREATMENT OF PHYMOSISInfo
- Publication number
- AR032208A1 AR032208A1 ARP010106081A ARP010106081A AR032208A1 AR 032208 A1 AR032208 A1 AR 032208A1 AR P010106081 A ARP010106081 A AR P010106081A AR P010106081 A ARP010106081 A AR P010106081A AR 032208 A1 AR032208 A1 AR 032208A1
- Authority
- AR
- Argentina
- Prior art keywords
- corticosteroids
- treatment
- pharmaceutical composition
- use based
- phymosis
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 5
- 229960001334 corticosteroids Drugs 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 230000003054 hormonal effect Effects 0.000 abstract 2
- 206010034878 phimosis Diseases 0.000 abstract 2
- 230000000699 topical effect Effects 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 210000003953 foreskin Anatomy 0.000 abstract 1
- 230000002797 proteolythic effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 239000012049 topical pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composicion farmacéutica de uso topico para el tratamiento de la fimosis, a base de corticosteroides asociados a una enzima difusora. Composicion farmacéutica para uso topico a base de corticoesteroides que comprende entre aproximadamente 0,025 y 5% en peso en relacion al peso total de la mezcla de la composicion de la mezcla de uno o más corticoesteroides y/o esteroides hormonales, asociados o no a antiinflamatorios no hormonales en una concentracion comprendida entre aproximadamente 25 UTR y 4000 UTR/g de una o más enzimas difusoras proteolíticas en un vehículo apropiado, bajo diferentes formas farmacéuticas acompanadas de aditivos conocidos por los expertos en la técnica. Aplicacion topica de corticoesteroides asociados a una enzima difusora, para el tratamiento de fimosis, donde un total de 90% de los pacientes presentaron mejoría de las dolencias clínicas, pudiendo retraer el prepucio sin dificultad.A topical pharmaceutical composition for the treatment of phimosis, based on corticosteroids associated with a diffusing enzyme. Pharmaceutical composition for topical use based on corticosteroids comprising between approximately 0.025 and 5% by weight in relation to the total weight of the mixture of the composition of the mixture of one or more corticosteroids and / or hormonal steroids, whether or not associated with anti-inflammatory drugs. hormonal levels in a concentration between approximately 25 UTR and 4000 UTR / g of one or more proteolytic diffusion enzymes in an appropriate vehicle, under different pharmaceutical forms accompanied by additives known to those skilled in the art. Topical application of corticosteroids associated with a diffuser enzyme, for the treatment of phimosis, where a total of 90% of patients presented improvement of clinical ailments, being able to retract the foreskin without difficulty.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR0006556-0A BR0006556A (en) | 2000-12-28 | 2000-12-28 | Pharmaceutical composition for topical use of corticosteroids for the treatment of phimosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032208A1 true AR032208A1 (en) | 2003-10-29 |
Family
ID=36686652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010106081A AR032208A1 (en) | 2000-12-28 | 2001-12-27 | PHARMACEUTICAL COMPOSITION FOR TOPIC USE BASED ON CORTICOSTEROIDS FOR THE TREATMENT OF PHYMOSIS |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7666858B2 (en) |
| EP (1) | EP1365766B1 (en) |
| JP (1) | JP5095907B2 (en) |
| CN (1) | CN1270719C (en) |
| AR (1) | AR032208A1 (en) |
| AU (1) | AU2002221365A1 (en) |
| BR (1) | BR0006556A (en) |
| DE (1) | DE60121047T2 (en) |
| ES (1) | ES2267671T3 (en) |
| MX (1) | MXPA03005813A (en) |
| RU (1) | RU2279893C2 (en) |
| WO (1) | WO2002053137A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070134232A1 (en) * | 2005-12-14 | 2007-06-14 | Joel Studin | Topical bite care composition |
| US20070225670A1 (en) * | 2006-03-14 | 2007-09-27 | Connell Thomas J | Diapers for improving male genital health and methods of using the same |
| WO2008101098A2 (en) * | 2007-02-15 | 2008-08-21 | Allergan, Inc. | Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis |
| IN2013CN00342A (en) * | 2010-06-17 | 2015-07-03 | Nitto Denko Corp | |
| US9878046B2 (en) | 2010-07-20 | 2018-01-30 | Halozyme, Inc. | Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| CN102302779A (en) * | 2011-07-29 | 2012-01-04 | 岳中瑾 | Cream preparation used for treating phimosis, and application thereof |
| RU2569431C2 (en) * | 2013-07-08 | 2015-11-27 | Александр Васильевич Газаматов | Method of conservative phimosis treatment |
| US10058542B1 (en) | 2014-09-12 | 2018-08-28 | Thioredoxin Systems Ab | Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith |
| CN110314168A (en) * | 2019-07-27 | 2019-10-11 | 清远市人民医院 | A kind of pharmaceutical composition and preparation method thereof for treating phimosis in children |
| RU2730476C1 (en) * | 2019-12-24 | 2020-08-24 | федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" | Anti-inflammatory ointment for animals |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2058780C1 (en) * | 1992-11-17 | 1996-04-27 | Совместное русско-американское акционерное общество закрытого типа "Неофарм" | Agent showing tonic action on the vein, bladder and prostate gland smooth muscle |
-
2000
- 2000-12-28 BR BR0006556-0A patent/BR0006556A/en active Search and Examination
-
2001
- 2001-12-13 EP EP01272567A patent/EP1365766B1/en not_active Expired - Lifetime
- 2001-12-13 AU AU2002221365A patent/AU2002221365A1/en not_active Abandoned
- 2001-12-13 MX MXPA03005813A patent/MXPA03005813A/en active IP Right Grant
- 2001-12-13 JP JP2002554088A patent/JP5095907B2/en not_active Expired - Fee Related
- 2001-12-13 WO PCT/BR2001/000154 patent/WO2002053137A2/en not_active Ceased
- 2001-12-13 DE DE60121047T patent/DE60121047T2/en not_active Expired - Lifetime
- 2001-12-13 ES ES01272567T patent/ES2267671T3/en not_active Expired - Lifetime
- 2001-12-13 US US10/465,977 patent/US7666858B2/en not_active Expired - Fee Related
- 2001-12-13 CN CNB01822296XA patent/CN1270719C/en not_active Expired - Fee Related
- 2001-12-13 RU RU2003119439/15A patent/RU2279893C2/en not_active IP Right Cessation
- 2001-12-27 AR ARP010106081A patent/AR032208A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20040067922A1 (en) | 2004-04-08 |
| WO2002053137A3 (en) | 2003-04-24 |
| ES2267671T3 (en) | 2007-03-16 |
| US7666858B2 (en) | 2010-02-23 |
| DE60121047T2 (en) | 2007-06-21 |
| CN1487833A (en) | 2004-04-07 |
| DE60121047D1 (en) | 2006-08-03 |
| AU2002221365A1 (en) | 2002-07-16 |
| CN1270719C (en) | 2006-08-23 |
| JP2004519451A (en) | 2004-07-02 |
| WO2002053137A2 (en) | 2002-07-11 |
| RU2003119439A (en) | 2005-02-27 |
| MXPA03005813A (en) | 2005-02-14 |
| EP1365766A2 (en) | 2003-12-03 |
| RU2279893C2 (en) | 2006-07-20 |
| HK1060850A1 (en) | 2004-08-27 |
| JP5095907B2 (en) | 2012-12-12 |
| BR0006556A (en) | 2002-09-17 |
| EP1365766B1 (en) | 2006-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2162517T3 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF METFORMIN AND FIBRATE AND ITS USE IN THE PREPARATION OF DRUGS INTENDED TO REDUCE HYPERGLYCEMIA. | |
| AR033808A1 (en) | A TOPICAL COMPOSITION OF LOCAL ANESTHESIA AND THE PATCHES AND CONTAINERS CONTAINING IT | |
| DK0969813T3 (en) | Topical pharmaceutical composition comprising a cholinergic or calcium channel blocking agent | |
| DZ3221A1 (en) | NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT | |
| AR032208A1 (en) | PHARMACEUTICAL COMPOSITION FOR TOPIC USE BASED ON CORTICOSTEROIDS FOR THE TREATMENT OF PHYMOSIS | |
| AR063201A1 (en) | PHARMACEUTICAL COMPOSITIONS OF ROPINIROL AND METHODS OF USE OF THE SAME | |
| NO20003546L (en) | Use of progestin and a pharmaceutical composition as well as a kit containing these | |
| ES2190472T3 (en) | TRANSDERMIC PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, ONLY OR IN COMBINATION WITH A STROGEN. | |
| DE60313597D1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS WITH PROANTHOCYANIDINES, GLYCYRRHETINIC ACID AND TELEMINE TESTS FOR THE TREATMENT OF DERMATITIS | |
| ES2188656T3 (en) | ANTIVIRAL COMPOSITION FOR THE CICATRIZATION OF A WOUND THAT CONTAINS A PIRUVATE, AN ANTIOXIDANT, A MIXED SATURATED FATTY ACIDS AND AN ANTI-VIRAL COMPOUND. | |
| DE50312034D1 (en) | LIPOSOMAL GLUCOCORTICOID | |
| AR029356A1 (en) | THE USE OF A HAIR BENEFIT AGENT AS AN INGREDIENT IN A TOPICAL COMPOSITION FOR HAIR TREATMENT | |
| AR062775A1 (en) | PHARMACEUTICAL COMPOSITION ABLE TO IMPROVE THE ACTIVITY OF LPG -1 IN A HUMAN BEING AND ITS USE TO PREPARE A MEDICINAL PRODUCT | |
| PE20040068A1 (en) | ETONOGESTREL DECANOATE, UNDECANOATE AND DODECANOATE | |
| BRPI0416275A (en) | methods of treating, controlling or preventing specific cancer and a disease associated with unwanted angiogenesis | |
| ES2171589T3 (en) | SOLID PHARMACEUTICAL COMPOSITIONS ANHYDRA FOR VAGINAL USE. | |
| TR199802769T2 (en) | Topical composition containing a combination of terpenoid compounds and antihistamine compounds. | |
| DK1280558T3 (en) | Semi-solid administration vehicle and pharmaceutical compositions | |
| ES2103493T3 (en) | USE OF PARATHORMONE, ITS BIOLOGICALLY ACTIVE FRAGMENTS AND RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY. | |
| AR051765A1 (en) | COMPOUNDS OF MOLECULES CONJUGATED WITH A REINFORCED ACTIVITY OF CELL ABSORPTION | |
| ES2174533T3 (en) | USE OF A MIXTURE OF A DIOL AND AN ALFA-HYDROXY ACID FOR THE TREATMENT OF HYPERQUERATOTIC SKIN DISEASES. | |
| ES2165948T3 (en) | THERMOSTABLE CRYSTAL MODIFICATION AND SUITABLE FOR STORAGE OF N-METHYL-N - ((1S) -1-PHENYL-2 - ((3S) -3-HIDROXI-PIRROLIDIN-1-IL) -ETIL) -2,2-DIFENIL- ACETAMIDE, AND PROCEDURE FOR OBTAINING. | |
| ES2191358T3 (en) | USE OF AN AROMATASE INHIBITOR IN THE TREATMENT OF A DECREASE IN THE RELATIONSHIP OF ANDROGENS TO STROGENS AND OF DYNERGY BETWEEN THE DETRUSOR AND THE URETRAL SPHINTER IN MEN AND METHODS TO STUDY THE DISINERGY IN MALE ROUNDERS. | |
| PE20050665A1 (en) | SELECTIVE ESTROGENS OF 8ß-VINYL-ESTRA-1,3,5 (10) -TRIEN-3,17ß-DIOL AND 17ß-FLUOR-9-VINYL-ESTRA-1,3,6 (10) -TRIEN-3,16ALPHA -DIOL | |
| CY1108785T1 (en) | STABLE MEDICINAL GEL DICLOFENAC NA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |